SPONSOR

Wake Forest University Health Sciences

Total Trials

Recruiting

Phases

Phase 3, Phase 2, Phase 4

Conditions studied: Bone Loss Triple Negative Breast Cancer Vitamin D Deficiency Invasive Breast Cancer Leukemia, Myeloid, Acute Acute Pain Colorectal Cancer Sarcopenia Food Insecurities Cardiometabolic Comorbidities

Wake Forest University Health Sciences is a clinical research sponsor with 26 registered studies on ClinicalTrials.gov, of which 26 are actively recruiting participants. Research covers conditions including Bone Loss, Triple Negative Breast Cancer, Vitamin D Deficiency, Invasive Breast Cancer.

The trial portfolio spans Phase 3, Phase 2, Phase 4 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.

Frequently Asked Questions — Wake Forest University Health Sciences

How many clinical trials has Wake Forest University Health Sciences sponsored?

ClinicalMetric currently tracks 26 clinical trials sponsored by Wake Forest University Health Sciences, of which 26 are actively recruiting participants. These trials cover conditions including Bone Loss, Triple Negative Breast Cancer, Vitamin D Deficiency. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.

What therapeutic areas does Wake Forest University Health Sciences research focus on?

Wake Forest University Health Sciences clinical trials span Bone Loss, Triple Negative Breast Cancer, Vitamin D Deficiency, Invasive Breast Cancer, Leukemia, Myeloid, Acute, and additional conditions. The research pipeline includes Phase 3, Phase 2, Phase 4 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.

How do I participate in a Wake Forest University Health Sciences clinical trial?

To participate in a Wake Forest University Health Sciences trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Wake Forest University Health Sciences trials with current recruitment status updated daily.

Wake Forest University Health Sciences

Frequently Asked Questions — Wake Forest University Health Sciences

Clinical Trials by Wake Forest University Health Sciences

Bisphosphonate Use to Mitigate Bone Loss Secondary to Bariatric Surgery

Impact of Vitamin D Supplementation on the Rate of Pathologic Complete Response in Vitamin D Deficient Patients

Toxicity Genetic Determinants and Response to Azacitidine and Venetoclax in AML

Bone, Exercise, Alendronate, and Caloric Restriction

Effects Of Intravenous Oxytocin On Peripheral Sensory Afferents Using Microneurography

Myopenia and Mechanisms of Chemotherapy Toxicity in Older Adults With Colorectal Cancer

Human Immunodeficiency Virus (HIV) Food Insecurities

MRI in High-Grade Glioma Patients Undergoing Chemoradiation

Appalachian Partnership to Reduce Disparities (Aim 2)

Immune Function and Response to Vaccination After Cancer Therapy in Pediatric Patients

Evaluation of Flexible Conductive Hearing Aids

Prospective Evaluation Of High-Dose Systemic Methotrexate In Patients With Breast Cancer And Leptomeningeal Metastasis

Neoadjuvant Chemotherapy for Borderline Resectable and Locally Advanced Pancreatic Adenocarcinoma

Effectiveness of Magnesium in Addition to Prochlorperazine for the Treatment of Migraines

Microneedling vs Dermabrasion for Early Facial Scar Resurfacing

Investigation of PEMF Therapy for Female Patients With IC/BPS

A Novel Dialectical Behavior Therapy Brief Group Intervention for Cigarette Smoking by Patients With Cancer: An Open Clinical Trial

CARE-CP (Testing a Cardiovascular Ambulatory Rapid Evaluation for Patients With Chest Pain)

Fatty Acid Synthase Inhibition in Castration Refractory Prostate Cancer

Emergency Medicine Cardiovascular Risk Assessment for Lipid Disorders Trial

Take A Break - Rural

Reducing Risk for Infective Endocarditis

A Pilot Study of Revian Red All LED Cap as a Novel Treatment for Central Centrifugal Cicatricial Alopecia

NextGen - Clinical Implication of Next Generation Sequencing

First Line Weekly Chemo/Immunotherapy for Metastatic Head/Neck Squamous Cell Carcinoma Patients

Randomized Controlled Trial for Treatment of Pain and Assessment of Wound Healing in Chronic Venous Leg Ulcers Using Near Infrared Laser Therapy